NYSE:CTEV Claritev (CTEV) Stock Price, News & Analysis $32.58 +0.56 (+1.75%) As of 07/9/2026 03:57 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Claritev Stock (NYSE:CTEV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Claritev alerts:Sign Up Key Stats Today's Range$30.92▼$33.4050-Day Range$13.70▼$34.8952-Week Range$11.50▼$74.07Volume65,027 shsAverage Volume118,188 shsMarket Capitalization$555.49 millionP/E RatioN/ADividend YieldN/APrice Target$33.67Consensus RatingModerate Buy Company Overview Claritev is a healthcare technology, data and insights company focused on improving affordability, transparency and quality. Led by deeply experienced associates, data scientists, and innovators, Claritev provides tech-enabled solutions and services fueled by multiple data sources from over 40 years of claims repricing. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design. By focusing on purpose-built solutions that support all key players — including payors, employers, patients, providers and third parties — we aim to make healthcare more accessible and affordable for all. AI Generated. May Contain Errors. Read More Claritev Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks27th Percentile Overall ScoreCTEV MarketRank™: Claritev scored higher than 27% of companies evaluated by MarketBeat, and ranked 719th out of 845 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.4 / 5Analyst RatingModerate Buy Consensus RatingClaritev has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on no strong buy ratings, 5 buy ratings, 1 hold rating, and 1 sell rating.Upside/DownsideThe consensus price target for Claritev is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageClaritev has only been the subject of 4 research reports in the past 90 days.Read more about Claritev's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Claritev are expected to grow in the coming year, from ($15.67) to ($12.66) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Claritev is -1.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Claritev is -1.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.22% of the float of Claritev has been sold short.Short Interest Ratio / Days to CoverClaritev has a short interest ratio ("days to cover") of 10.86, which indicates bearish sentiment.Change versus previous monthShort interest in Claritev has recently decreased by 2.21%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldClaritev does not currently pay a dividend.Dividend GrowthClaritev does not have a long track record of dividend growth. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Claritev this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for CTEV on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Company Ownership3.1 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $24,859.00 in company stock, which represents 0.0045% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Claritev insiders have bought more of their company's stock than they have sold. Specifically, they have bought $24,859.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders7.40% of the stock of Claritev is held by insiders.Percentage Held by Institutions87.15% of the stock of Claritev is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Claritev's insider trading history. Receive CTEV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Claritev and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CTEV Stock News HeadlinesClaritev (NYSE:CTEV) Given Consensus Rating of "Moderate Buy" by AnalystsJuly 8 at 4:47 AM | americanbankingnews.comClaritev (CTEV) Stock Faces Mixed Analyst Target Changes As Growth Execution Questions BuildJune 26, 2026 | finance.yahoo.comPorter flew 3,300 miles to investigate this systemPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.July 10 at 1:00 AM | Porter & Company (Ad)Claritev Corporation Announces Participation in Truist Securities Healthcare Disruptors & Digital Health ConferenceJune 23, 2026 | businesswire.comClaritev Cleared of Criminal Probe, Faces Civil InquiryJune 22, 2026 | tipranks.comHow The Claritev (CTEV) Investment Story Is Evolving As The Market Holds Its Fair Value ViewJune 11, 2026 | finance.yahoo.comInsider Buying: Claritev (NYSE:CTEV) SVP Buys 875 Shares of StockJune 11, 2026 | insidertrades.comTop Claritev Executive Makes Bold Insider Move on Company StockJune 10, 2026 | tipranks.comSee More Headlines CTEV Stock Analysis - Frequently Asked Questions How have CTEV shares performed this year? Claritev's stock was trading at $42.78 at the beginning of the year. Since then, CTEV shares have decreased by 23.8% and is now trading at $32.58. How were Claritev's earnings last quarter? Claritev (NYSE:CTEV) announced its quarterly earnings results on Thursday, August, 1st. The company reported ($1.20) EPS for the quarter, beating the consensus estimate of ($1.60) by $0.40. The firm earned $233.48 million during the quarter, compared to analysts' expectations of $253.59 million. Read the conference call transcript. When did Claritev's stock split? Claritev shares reverse split on Monday, September 23rd 2024.The 1-40 reverse split was announced on Tuesday, September 10th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, September 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. How do I buy shares of Claritev? Shares of CTEV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/01/2024Today7/10/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 CTEV's financial health is in the Green zone, according to TradeSmith. CTEV has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Business services, not elsewhere classified Sub-IndustryBusiness Services Current SymbolNYSE:CTEV CIK1793229 Webwww.claritev.com Phone1-800-677-1098FaxN/AEmployees3,000Year Founded1980Price Target and Rating Average Price Target for Claritev$33.67 High Price Target$61.00 Low Price Target$21.00 Potential Upside/Downside+3.3%Consensus RatingModerate Buy Rating Score (0-4)2.57 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)($17.33) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$284.28 million Net Margins-29.27% Pretax Margin-38.41% Return on EquityN/A Return on Assets-4.36% Debt Debt-to-Equity RatioN/A Current Ratio1.28 Quick Ratio1.28 Sales & Book Value Annual Sales$965.41 million Price / Sales0.58 Cash Flow$15.74 per share Price / Cash Flow2.07 Book Value($10.10) per share Price / Book-3.23Miscellaneous Outstanding Shares17,050,000Free Float15,786,000Market Cap$555.49 million OptionableOptionable Beta0.69 Social Links 10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free Report This page (NYSE:CTEV) was last updated on 7/10/2026 by MarketBeat.com Staff. From Our PartnersBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredRay Dalio: Buy Gold. Get Paid.Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...Investors Alley | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredYour book attachedBill Poulos is giving away his 'Simple Options Trading For Beginners' book at no cost - normally $29.97. It ou...Profits Run | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredThe tiny chipmaker set to supply Musk 5 billion chipsSpaceX and xAI just completed a $1.25 trillion merger - and Musk may no longer need data centers from Microsof...Brownstone Research | SponsoredThe market’s crashing? … There’s an app for thatDuring the Great Financial Crisis, one firm accurately predicted 464 of 465 bank failures before they happened...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Claritev Please log in to your account or sign up in order to add this asset to your watchlist. Share Claritev With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
